HRSA BPHC Technical Assistance Office Hours

Webinar Date: Thursday, May 30, 2024

Join us for an insightful panel discussion on the intersection of aging, cognitive health and substance use disorders (SUD) in older adults. Our expert panelists will explore the complexities of this growing public health concern and share practical strategies for adapting screening, assessment, and treatment for older patients with SUDs. Our panel will address audience questions and provide valuable perspectives to empower healthcare providers in delivering comprehensive care for older adults with SUDs.

At the end of this webinar, participants will be able to:

• Identify the impact of SUDs on older adults’ cognitive impairment.
• Describe clinical evaluation for SUDs in an older adults with cognitive impairment.
• Incorporate SUD care into an older adult’s brain health plan.
• Adapt SUD treatment for an older adult with cognitive impairment.

Speaker Information:

Triveni DeFries, MD, MPH is an Assistant Clinical Professor of Internal Medicine at the University of California, San Francisco (UCSF), where she also completed a fellowship in Primary Care Addiction Medicine. She is a clinician-educator and addiction medicine physician at San Francisco General Hospital’s general adult medicine primary care clinic and attends on the hospital’s inpatient addiction medicine consult service.

Christy Soran, MD, MPH is the Deputy Medical Director for Substance Use Services for the San Francisco Department of Public Health.  Prior to this role, Christy was a medical educator and primary care physician at UCSF and the Medical Director at the UCSF Outpatient Buprenorphine Induction Clinic.

Anna Chodos, MD, MPH is an Associate Professor of Clinical Medicine at UCSF in the Division of Geriatrics and the Division of General Internal Medicine. She is the Medical Director of Outpatient Geriatrics at Zuckerberg San Francisco General Hospital.

—

View the Webinar:

—

The planners and speakers for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

The National Clinician Consultation Center is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $2,633,756 with 0% financed with non-governmental sources (grant number U1OHA30039, awarded to the University of California San Francisco, and in partnership with the Centers for Disease Control and Prevention).

The content in this presentation are those of the authors and does not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.